In Vitro Effectiveness of Meropenem and Cefmetazole Combination Treatment Against KPC-2-Producing Enterobacteriaceae

Abstract

Purpose:

Optimal treatment regimens are yet to be established for carbapenemase-producing Enterobacteriaceae (CPE). We assessed the in vitro efficacy of meropenem (MEM) and cefmetazole (CMZ) combination treatment against bla_KPC-2-positive Enterobacteriaceae, in comparison with that of double-carbapenem therapy using ertapenem (ERT).

Materials and Methods:

We performed checkerboard assay for 10 bla_KPC-2-positive clinical isolates and Klebsiella pneumoniae BAA-1705 (possessing bla_KPC-2), with synergistic effect being defined by a fractional inhibitory concentration index of ≤0.5. Subsequently, we conducted time–kill assays using K. pneumoniae BAA-1705 with an initial inoculum of 10⁴–10⁷ colony forming unit (CFU)/mL. Bactericidal effect was defined as the reduction of initial bacterial count by ≥10³ CFU/mL in 24 hr. Finally, we applied scanning electron microscopy to observe morphological changes induced by the combination of MEM and CMZ.

Results:

Checkerboard assays revealed a synergistic effect in 7 out of 11 bla_KPC-2 -positive Enterobacteriaceae when the MEM and CMZ combination was used, and no effect when the MEM and ERT combination was used. The minimum inhibitory concentration of MEM decreased 4–8-fold when combined with CMZ. Time–kill assays with an initial inoculum of 5 × 10⁵ CFU/mL revealed regrowth under the combination of MEM and ERT (0.25 × minimum inhibitory concentration [MIC] each), whereas the combination of 0.25 × MIC each of MEM and CMZ exhibited bactericidal effect. Scanning electron microscopy results demonstrated that the combination of 0.5 × MIC MEM and 0.5 × MIC CMZ facilitated bacterial cell lysis compared with each antibiotic alone.

Conclusion:

The combination therapy using MEM and CMZ potentially has bactericidal effect against KPC-producing Enterobacteriaceae.